The authors first divided solid tumor patients into two categories, those with a positive versus no correlation between CD8 T-cell levels and neoantigen load, a term referring to the presumption that higher amounts of tumor mutations lead to certain antigen peptides which in turn activate the immune system. This evidence concerns the gene CD8A and neoplasm.